| Serial Number | 99218533 |
| Word Mark | BLUEFIN BIOMEDICINE |
| Filing Date | Wednesday, June 4, 2025 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, December 2, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, December 2, 2025 |
| Description of Mark | The mark consists of a stylized fin to the left of a circle, where the fin and circle combined make a stylized person, all above the word "Bluefin" above "BIOMEDICINE". |
| Pseudo Mark | BLUE FIN BIO MEDICINE |
| Goods and Services | Antibodies for medical purposes; Diagnostic biomarker reagents for medical purposes; Protein arrays for medical diagnosis purposes; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Diagnostic preparations for medical purposes; Pharmaceutical preparations for the treatment of cancer, oncologic diseases and disorders, inflammation and immunity diseases and disorders, immunodeficiency diseases and disorders, genetic diseases and disorders, metabolic diseases and disorders, neurodegenerative diseases and disorders, kidney diseases and disorders, eye diseases and disorders, uveitis, glomerulosclerosis, glomerulonephritis, cardiovascular diseases and disorders |
| NOT AVAILABLE | "BIOMEDICINE" |
| Goods and Services | Pharmaceutical research and development; Research and development services in the field of antibodies; Providing medical and scientific research information; Consulting services in the field of pharmaceutical research and development; Consulting services in the field of biotechnology; Consulting services in the field of pharmacogenetics; Research and development in the field of biologics, namely, antibodies and peptides for the field of cancer, immunology and inflammation diseases, autoimmune diseases, autoimmune disorders, genetic disorders, metabolic diseases, neurodegenerative diseases, kidney diseases, eye diseases, uveitis, glomerulosclerosis, glomerulonephritis, and cardiovascular diseases; Research and development in the field of pharmaceuticals, biopharmaceuticals, and biotechnologies for the treatment of cancer, immunology and inflammation diseases, autoimmune diseases, autoimmune disorders, genetic disorders, metabolic diseases, neurodegenerative diseases, kidney diseases, eye diseases, uveitis, glomerulosclerosis, glomerulonephritis, and cardiovascular diseases; Research and development in the field of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics in the field of cancer, immunology and inflammation diseases, autoimmune diseases, autoimmune disorders, genetic disorders, metabolic diseases, neurodegenerative diseases, kidney diseases, eye diseases, uveitis, glomerulosclerosis, glomerulonephritis, and cardiovascular diseases; Research and development in the field of proteomics, transcriptomics, and bioinformatics |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, June 4, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, June 4, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Bluefin Biomedicine, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Beverly, MA 01915 |
| Party Name | Bluefin Biomedicine, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Beverly, MA 01915 |
| Event Date | Event Description |
| Wednesday, June 4, 2025 | NEW APPLICATION ENTERED |
| Wednesday, June 4, 2025 | APPLICATION FILING RECEIPT MAILED |
| Friday, October 10, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, October 10, 2025 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Friday, October 24, 2025 | ASSIGNED TO EXAMINER |
| Thursday, October 30, 2025 | EXAMINERS AMENDMENT -WRITTEN |
| Thursday, October 30, 2025 | EXAMINERS AMENDMENT E-MAILED |
| Thursday, October 30, 2025 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Thursday, October 30, 2025 | EXAMINER'S AMENDMENT ENTERED |
| Friday, October 31, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, November 26, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, December 2, 2025 | PUBLISHED FOR OPPOSITION |
| Tuesday, December 2, 2025 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |